semaglutide bone mineral density New studies have raised fresh alarms about the popular “weight-loss drug” Ozempic, revealing it may accelerate loss and weaken skeletal health in users. Research published in 2025–2026 shows patients on A study presented at the

Alternatively, combining with lifestyle adjustments or switching to a dual-pathway therapy like GLP-Squared may reignite weight loss if recommended by genetic testing or clinical assessment

As a first approach we utilized allulose (1 g/kg, gavage) as a GLP1 secretagogue (Hayakawa et al., 2018) to co-treat with olanzapine (5 mg/kg, IP) (Figure 1A)

Waldman Department of Dermatology in New York City, and his team helped design the new trial, which will be launched soon

This is why regular foot checks are important, especially for those with diabetes

Do you have any, like, thoughts or any words outside of anything that you've already shared to maybe help them navigate their own journey with using GLP-1 medications or any of those